X‐Ray‐Responsive Mn 2+ Release via Scintillating Nanoparticles Drives cGAS‐STING Activation for Enhanced Radio‐Immunotherapy
Small · 2026
DOI: 10.1002/smll.73513 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2026. Verfasst von Kai Deng und 13 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, P. R. China. Hauptthemen laut MEDLINE: cGAS-STING Signaling Pathway, Immunotherapy, Manganese, Membrane Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Radiotherapy (RT) represents a potent approach to activate the cyclic GMP‐AMP synthase (cGAS)–stimulator of interferon genes (STING) pathway. However, this immune activation is typically transient and insufficient for long‐term tumor control. To overcome this limitation, we developed SCYS‐P@MnCO, an X‐ray‐responsive nanoplatform that integrates radioluminescent scintillating nanoparticles (SCNPs) with photosensitive manganese carbonyl complexes (MnCOs). This design enables the precise, spatiotemporally controlled release of Mn 2+ and carbon monoxide (CO) within the tumor microenvironment. The released Mn 2+ significantly sensitizes cGAS to cytosolic DNA, thereby amplifying STING signaling to promote interferon‐β secretion and dendritic cell maturation. When combined with RT, SCYS‐P@MnCO not only sensitizes tumors to radiation by CO but also induces a potent systemic immune response mediated by Mn 2+ . Together, this X‐ray‐responsive nanoplatform synergistically enhances radiosensitivity while amplifying innate immune activation, providing an effective strategy for advancing radio‐immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, P. R. China.
- Department of Clinical Laboratory, Zhejiang Key Laboratory of Functional Nucleic Acids for Basic and Clinical Application, Zhejiang Cancer Hospital, Hangzhou, Institute of Medicine (HIM), Chinese Academy of Sciences, Ha…
- School of Medicine, Eye Center of Second Affiliated Hospital, Zhejiang University, Hangzhou, P. R. China.
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, P. R. China.
ORCID-Profile: Zhen Du
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Zhejiang Provincial Natural Science Foundation of China
- "Pioneer" and "Leading Goose" R&D Program of Zhejiang
Zitieren
APA
Deng, K., Zheng, Y., Han, Y., Xie, Y., Luo, Z., Li, Y., Jiang, J., Qin, Z., Shi, X., Yang, H., Yang, Y., Shi, Q., Liu, X., & Du, Z. (2026). X‐Ray‐Responsive Mn 2+ Release via Scintillating Nanoparticles Drives cGAS‐STING Activation for Enhanced Radio‐Immunotherapy. Small. https://doi.org/10.1002/smll.73513
Vancouver
Deng K, Zheng Y, Han Y, Xie Y, Luo Z, Li Y, et al. X‐Ray‐Responsive Mn 2+ Release via Scintillating Nanoparticles Drives cGAS‐STING Activation for Enhanced Radio‐Immunotherapy. Small. 2026. doi:10.1002/smll.73513
BibTeX
@article{Deng2026,
author = {Deng, Kai and Zheng, Yile and Han, Yuqi and Xie, Yichen and Luo, Zhenzhen and Li, Yuting and Jiang, Jinhong and Qin, Zhihui and Shi, Xiayu and Yang, Honghong and Yang, Yuying and Shi, Qiwen and Liu, Xiangsheng and Du, Zhen},
title = {X‐Ray‐Responsive Mn 2+ Release via Scintillating Nanoparticles Drives cGAS‐STING Activation for Enhanced Radio‐Immunotherapy},
journal = {Small},
year = {2026},
doi = {10.1002/smll.73513}
}
EUVIMED